| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.55 | 0.0009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.05 |